scholarly article | Q13442814 |
P50 | author | David A. Fiellin | Q38800653 |
Vincent C Marconi | Q41553111 | ||
Amy C Justice | Q42395670 | ||
James Dziura | Q85558986 | ||
E Jennifer Edelman | Q86191217 | ||
Lynn E. Fiellin | Q86575062 | ||
P2093 | author name string | David Rimland | |
Maria C Rodriguez-Barradas | |||
Patrick G O'Connor | |||
Christopher J Cutter | |||
Kendall J Bryant | |||
Stephen A Maisto | |||
Nathan B Hansen | |||
Cynthia Gibert | |||
Roger Bedimo | |||
Michael S Simberkoff | |||
P2860 | cites work | The PHQ-9: validity of a brief depression severity measure | Q24550620 |
HIV infection and the risk of acute myocardial infarction | Q27347231 | ||
Screening for alcohol problems in primary care: a systematic review | Q28140448 | ||
The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test | Q28282539 | ||
Matching Alcoholism Treatments to Client Heterogeneity: Project MATCH posttreatment drinking outcomes | Q28300322 | ||
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire | Q29615435 | ||
2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8) | Q29617334 | ||
Development and implementation of an emergency practitioner-performed brief intervention for hazardous and harmful drinkers in the emergency department | Q30477037 | ||
The impact of brief alcohol interventions in primary healthcare: a systematic review of reviews. | Q30559758 | ||
An early evaluation of implementation of brief intervention for unhealthy alcohol use in the US Veterans Health Administration | Q30605503 | ||
Analyzing incomplete longitudinal clinical trial data | Q30939327 | ||
Managing attribute--value clinical trials data using the ACT/DB client-server database system | Q32077393 | ||
Brief intervention for hazardous and harmful drinkers in the emergency department | Q33641080 | ||
HIV care providers' implementation of routine alcohol reduction support for their patients | Q33875031 | ||
The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy | Q33881303 | ||
HIV Care Providers' Role Legitimacy as Supporters of Their Patients' Alcohol Reduction | Q33913835 | ||
Stepped care as a heuristic approach to the treatment of alcohol problems | Q34018646 | ||
Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: have we chosen the best designs? | Q34018867 | ||
Alcohol and HIV Disease Progression: Weighing the Evidence | Q34123580 | ||
Does an index composed of clinical data reflect effects of inflammation, coagulation, and monocyte activation on mortality among those aging with HIV? | Q34160020 | ||
Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases | Q34433709 | ||
Towards a combined prognostic index for survival in HIV infection: the role of 'non-HIV' biomarkers | Q34802684 | ||
An internationally generalizable risk index for mortality after one year of antiretroviral therapy. | Q34813110 | ||
Attitudes and Training Needs of New England HIV Care and Addiction Treatment Providers: Opportunities for Better Integration of HIV and Alcohol Treatment Services | Q35136597 | ||
Clinical practice. Unhealthy alcohol use. | Q36036196 | ||
Patient and provider priorities for self-reported domains of HIV clinical care | Q36277120 | ||
Unhealthy alcohol and illicit drug use are associated with decreased quality of HIV care | Q36287158 | ||
Phosphatidylethanol in blood as a marker of chronic alcohol use: a systematic review and meta-analysis | Q36432550 | ||
Implementation of integrated stepped care for unhealthy alcohol use in HIV clinics. | Q36457683 | ||
Number of Drinks to "Feel a Buzz" by HIV Status and Viral Load in Men | Q36658106 | ||
Risk of mortality and physiologic injury evident with lower alcohol exposure among HIV infected compared with uninfected men. | Q36689488 | ||
Predictive accuracy of the Veterans Aging Cohort Study index for mortality with HIV infection: a North American cross cohort analysis | Q36747893 | ||
A new measure of substance abuse treatment. Initial studies of the treatment services review | Q36767384 | ||
Perceived medical risks of drinking, alcohol consumption, and hepatitis C status among heavily drinking HIV primary care patients | Q36837338 | ||
Correlates of sex without serostatus disclosure among a national probability sample of HIV patients | Q36938248 | ||
Untreated HIV infection is associated with higher blood alcohol levels | Q37045314 | ||
A brief intervention reduces hazardous and harmful drinking in emergency department patients | Q37263056 | ||
Drug treatment outcomes among HIV-infected opioid-dependent patients receiving buprenorphine/naloxone | Q37393366 | ||
Psychometric properties of the Fagerström Test for Nicotine Dependence | Q37393821 | ||
Relationship between alcohol use categories and noninvasive markers of advanced hepatic fibrosis in HIV-infected, chronic hepatitis C virus-infected, and uninfected patients. | Q37726058 | ||
Increasing burden of liver disease in patients with HIV infection | Q37860640 | ||
Stepped care treatment delivery for depression: a systematic review and meta-analysis | Q38234345 | ||
Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. | Q38407349 | ||
Evaluation of Stepped Care for Chronic Pain (ESCAPE) in Veterans of the Iraq and Afghanistan Conflicts: A Randomized Clinical Trial | Q38415223 | ||
Ethanol metabolites: their role in the assessment of alcohol intake. | Q38581962 | ||
Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection | Q39244103 | ||
Pharmacy-based assessment of adherence to HAART predicts virologic and immunologic treatment response and clinical progression to AIDS and death | Q39702981 | ||
Long-acting injectable depot naltrexone use in the Veterans' Health Administration: a national study | Q40119263 | ||
Phosphatidylethanol is superior to carbohydrate-deficient transferrin and γ-glutamyltransferase as an alcohol marker and is a reliable estimate of alcohol consumption level | Q40391238 | ||
Heavy Alcohol Use Is Associated With Worse Retention in HIV Care. | Q40481187 | ||
Engagement and Substance Dependence in a Primary Care-Based Addiction Treatment Program for People Infected with HIV and People at High-Risk for HIV Infection | Q40616512 | ||
Examining the Specification Validity of the HEDIS Quality Measures for Substance Use Disorders | Q41305410 | ||
Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials | Q42958010 | ||
Effect of Medication Adherence on Survival of HIV-Infected Adults Who Start Highly Active Antiretroviral Therapy When the CD4+ Cell Count Is 0.200 to 0.350 × 109 cells/L | Q43689007 | ||
Effects of two types of brief intervention and readiness to change on alcohol use in hazardous drinkers. | Q43795229 | ||
Long-term treatment with buprenorphine/naloxone in primary care: results at 2-5 years | Q44026322 | ||
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative | Q44141522 | ||
Pharmacotherapy for alcohol dependence: perceived treatment barriers and action strategies among Veterans Health Administration service providers | Q44737385 | ||
Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection | Q44920531 | ||
Use of naltrexone for alcohol use disorders in the Veterans' Health Administration: a national study | Q44967942 | ||
Implementation of evidence-based alcohol screening in the Veterans Health Administration. | Q45332595 | ||
Intoxication before intercourse and risky sexual behavior in male veterans with and without human immunodeficiency virus infection | Q45332697 | ||
A temporal and dose-response association between alcohol consumption and medication adherence among veterans in care | Q45333065 | ||
Role of alcohol in determining human immunodeficiency virus (HIV)-relevant outcomes: A conceptual model to guide the implementation of evidence-based interventions into practice | Q45414367 | ||
HIV-positive patients' discussion of alcohol use with their HIV primary care providers | Q46775961 | ||
The Fifth Edition of the Addiction Severity Index | Q51700999 | ||
Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. | Q52267385 | ||
Intermittent use of triple-combination therapy is predictive of mortality at baseline and after 1 year of follow-up | Q57259766 | ||
Associations Between Alcohol, Heroin, and Cocaine Use and High Risk Sexual Behaviors Among Detoxification Patients | Q58289995 | ||
A general method of compliance assessment using centralized pharmacy records. Description and validation | Q68455320 | ||
Sex without disclosure of positive HIV serostatus in a US probability sample of persons receiving medical care for HIV infection | Q73449527 | ||
P2507 | corrigendum / erratum | Corrigendum to "The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients" [Contemp. Clin. Trials 52 (2017) 8 | Q47825385 |
P407 | language of work or name | English | Q1860 |
P921 | main subject | alcohol consumption | Q2647488 |
P304 | page(s) | 80-90 | |
P577 | publication date | 2016-11-20 | |
P1433 | published in | Contemporary Clinical Trials | Q5164971 |
P1476 | title | The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for Three Parallel Multi-Site Stepped Care Effectiveness Studies for Unhealthy Alcohol Use in HIV-Positive Patients | |
P478 | volume | 52 |
Q44086645 | Fresh Perspectives on the Alcohol and HIV Nexus: A Call for Action in an Era of Increased Opportunities and Challenges |
Q92169547 | Integrated stepped alcohol treatment for patients with HIV and alcohol use disorder: a randomised controlled trial |
Q98163754 | Integrated stepped alcohol treatment for patients with HIV and at-risk alcohol use: a randomized trial |
Q90195508 | Integrated stepped alcohol treatment for patients with HIV and liver disease: A randomized trial |
Q53691763 | Perceptions of alcohol use in the context of HIV treatment: a qualitative study. |
Q47650978 | Racial/ethnic differences in the association between alcohol use and mortality among men living with HIV. |
Q90360776 | Strengths and Limitations of the Veterans Aging Cohort Study Index as a Measure of Physiologic Frailty |
Q47825385 | Corrigendum to "The Starting Treatment for Ethanol in Primary care Trials (STEP Trials): Protocol for three parallel multi-site stepped care effectiveness studies for unhealthy alcohol use in HIV-positive patients" [Contemp. Clin. Trials 52 (2017) 8 | main subject | P921 |
Search more.